StockNews.com started coverage on shares of Actinium Pharmaceuticals (NYSE:ATNM – Get Rating) in a report released on Thursday morning. The brokerage issued a sell rating on the stock.
Actinium Pharmaceuticals Price Performance
Shares of NYSE:ATNM opened at $8.68 on Thursday. Actinium Pharmaceuticals has a 1 year low of $4.67 and a 1 year high of $15.12. The stock has a market cap of $223.34 million, a PE ratio of -5.56 and a beta of 0.38.
About Actinium Pharmaceuticals
- Get a free copy of the StockNews.com research report on Actinium Pharmaceuticals (ATNM)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for Actinium Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Actinium Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.